Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nectar Lifesciences has informed that it enclosed copy of Annual Report for the financial year ended on March 31, 2022, containing therein: Notice of 27th Annual General Meeting (AGM), Standalone Financial Statements, Directors and Auditors Report thereon, Consolidated Financial Statements and Auditors Report thereon, Corporate Governance Report, Management Discussion and Analysis Report along with Attendance Slip and E-voting Instructions. The above details are also available on the website of the Company. Consequent to resignation of Sanjit Singh Lamba, he is not being proposed to be appointed as a regular director as well as Wholetime Director in the AGM.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1696.65 |
| Dr. Reddys Lab | 1218.30 |
| Cipla | 1226.65 |
| Zydus Lifesciences | 936.00 |
| Lupin | 2339.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: